| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |